
Please try another search
Apimeds Pharmaceuticals US, Inc. operates as a clinical stage biopharmaceutical company in the United States. It researches, develops, manufactures, commercializes, and sells Apitox, a purified, pharmaceutical grade venom of the Apis mellifera, or honeybee for the treatment of inflammation and pain management symptoms associated with osteoarthritis and multiple sclerosis. The company was incorporated in 2020 and is based in Matawan, New Jersey.
Name | Age | Since | Title |
---|---|---|---|
Carol O’Donnell | 67 | 2023 | Independent Director |
Jakap Koo | 64 | 2023 | Director |
Christopher M. Kim | 74 | - | Chief Medical Officer & Chairman |
Erik C. Emerson | 54 | 2023 | CEO & Director |
Bennett C. Weintraub | 56 | 2023 | Independent Director |
Elona Kogan | 56 | 2024 | Independent Director |
Hankil Yoon | 62 | 2023 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review